CAMBRIDGE, Mass.--(BUSINESS WIRE)--ImmusanT Inc., a company focused on restoring tolerance to gluten and overcoming the need for gluten-free diet in patients with celiac disease, today announced that its immunotherapy, Nexvax2, has been selected by Informa for its annual list of “Top 10 Autoimmune/Anti-Inflammatory Projects to Watch.”
Help employers find you! Check out all the jobs and post your resume.
